Paper38517618
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B and 6 others. Cancer Metastasis Rev, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics. Papers, record 38517618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38517618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Plasticity | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Signal Transduction | |
| Epithelial-Mesenchymal Transition | |
| Drug Resistance, Neoplasm | |
| Receptors, Cytoplasmic and Nuclear | |
| Neoplastic Stem Cells |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R.G.P.2/555/44 | Deanship of Scientific Research at King Khalid University (KKU) | PubMed | ||
| BT/556/NE/U-Excel/2016 | Department of Biotechnology (DBT), Government of India | PubMed |
Source PubMed
References280
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 2 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 3 | 35022204 | Hallmarks of Cancer: New Dimensions. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35022204 | PubMed |
| 4 | 10647931 | The hallmarks of cancer. | Cell | 2000 | https://conductscience.org/library/papers/10647931 | PubMed |
| 5 | 30992279 | Cellular Plasticity in Cancer. | Cancer Discov | 2019 | https://conductscience.org/library/papers/30992279 | PubMed |
| 6 | 19006453 | Stem cells and the phenomena of plasticity and diversity: a limiting property of carcinogenesis. | Stem Cells Dev | 2008 | https://conductscience.org/library/papers/19006453 | PubMed |
| 7 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 8 | 30594349 | EMT Transition States during Tumor Progression and Metastasis. | Trends Cell Biol | 2019 | https://conductscience.org/library/papers/30594349 | PubMed |
| 9 | 29071215 | The Different Mechanisms of Cancer Drug Resistance: A Brief Review. | Adv Pharm Bull | 2017 | https://conductscience.org/library/papers/29071215 | PubMed |
| 10 | 26537958 | Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far. | Recent Pat Anticancer Drug Discov | 2016 | https://conductscience.org/library/papers/26537958 | PubMed |
| 11 | 30961357 | Cancer drug development: The missing links. | Exp Biol Med (Maywood) | 2019 | https://conductscience.org/library/papers/30961357 | PubMed |
| 12 | 15641020 | Molecular mechanisms of drug resistance. | J Pathol | 2005 | https://conductscience.org/library/papers/15641020 | PubMed |
| 13 | 8521507 | The nuclear receptor superfamily: the second decade. | Cell | 1995 | https://conductscience.org/library/papers/8521507 | PubMed |
| 14 | 28553937 | Stem cell plasticity enables hair regeneration following Lgr5+ cell loss. | Nat Cell Biol | 2017 | https://conductscience.org/library/papers/28553937 | PubMed |
| 15 | 29479084 | Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. | Nat Rev Genet | 2018 | https://conductscience.org/library/papers/29479084 | PubMed |
| 16 | 37789138 | Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/37789138 | PubMed |
| 17 | 32595946 | Cell plasticity in cancer cell populations. | F1000Res | 2020 | https://conductscience.org/library/papers/32595946 | PubMed |
| 18 | 30554963 | Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. | Cell Stem Cell | 2019 | https://conductscience.org/library/papers/30554963 | PubMed |
| 19 | 37853437 | Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37853437 | PubMed |
| 20 | 11689955 | Stem cells, cancer, and cancer stem cells. | Nature | 2001 | https://conductscience.org/library/papers/11689955 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42421656 | Ecdysone receptor autonomously controls germ cell differentiation in the Drosophila ovary. | Development | 2026 | https://conductscience.org/library/papers/42421656 | PubMed |
| 41497585 | Ecdysone Receptor autonomously controls germ cell differentiation in the Drosophila ovary. | bioRxiv | 2025 | https://conductscience.org/library/papers/41497585 | PubMed |
| 41462674 | The Redox-Adhesion-Exosome (RAX) Hub in Cancer: Lipid Peroxidation-Driven EMT Plasticity and Ferroptosis Defense with HNE/MDA Signaling and Lipidomic Perspectives. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41462674 | PubMed |
| 40806474 | Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806474 | PubMed |
| 39327610 | Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases. | Mil Med Res | 2024 | https://conductscience.org/library/papers/39327610 | PubMed |
| 39077471 | Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics. | Front Oncol | 2024 | https://conductscience.org/library/papers/39077471 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38517618
GET https://conductscience.org/api/papers/v1/38517618/references?page=2